The American Society of Regional Anesthesia and Pain Medicine (ASRA) convened its
Fourth Consensus Conference on Regional Anesthesia and Anticoagulation in conjunction …

D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated
degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of …

Background Patients with acute medical illnesses are at prolonged risk for venous
thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown …

An individualized approach to identify acutely ill medical patients at increased risk of venous
thromboembolism (VTE) and a low risk of bleeding to optimize the benefit and risk of …

BACKGROUND: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …

Background The IMPROVE score is a validated venous thromboembolism (VTE)
assessment tool to risk stratify hospitalized, medically ill patients based on clinical variables …

The use of warfarin, the most commonly prescribed oral anticoagulant, is being questioned
by clinicians worldwide due to warfarin several limitations (a limited therapeutic window and …

The direct oral anticoagulants (DOACs) represent a major advance in oral anticoagulant
therapy and have replaced the vitamin K antagonists as the preferred treatment for many …

Hypoalbuminemia is a common finding and independent predictor for unfavorable
prognosis. The prognostic value of albumin measurement for short‐term VTE prediction in …

Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary
embolism, is a common and potentially preventable cause of morbidity and mortality …